Assessing the Safety and Therapeutic Efficacy of Cannabidiol Lipid Nanoparticles in Alleviating Metabolic and Memory Impairments and Hippocampal Histopathological Changes in Diabetic Parkinson's Rats

• Main Authors: Sarawut Lapmanee (Author), Sakkarin Bhubhanil (Author), Prapimpun Wongchitrat (Author), Natthawut Charoenphon (Author), Anjaree Inchan (Author), Thitaphat Ngernsutivorakul (Author), Piroonrat Dechbumroong (Author), Mattaka Khongkow (Author), Katawut Namdee (Author)
• Format: Book
• Published: MDPI AG, 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Diabetic Parkinson's disease (DP) is a progressive neurodegenerative disease with metabolic syndrome that is increasing worldwide. Emerging research suggests that cannabidiol (CBD) is a neuropharmacological compound that acts against this disease, especially CBD in nano-formulation. The safety...